Literature DB >> 28289845

What's new in neuromyelitis optica? A short review for the clinical neurologist.

Daniel Whittam1, Martin Wilson1, Shahd Hamid1, Geoff Keir1, Maneesh Bhojak1, Anu Jacob2.   

Abstract

The evolution of neuromyelitis optica spectrum disorder (NMOSD) from a rare, incurable and misunderstood disease with almost universally poor outcomes to its present state in just over a decade is unprecedented in neurology and possibly in medicine. Our knowledge of NMOSD biology has led to the recognition of wider phenotypes, new disease mechanisms, and thus clinical trials of new and effective treatments. This article aims to update readers on the recent developments in NMOSD with particular emphasis on clinical advances, the 2015 diagnostic criteria, biomarkers, imaging, and therapeutic interventions.

Entities:  

Keywords:  Aquaporin; Myelin oligodendrocyte glycoprotein; Myelitis; Optic neuritis

Mesh：

Substances：

Year:  2017        PMID： 28289845     DOI： 10.1007/s00415-017-8445-8

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


  115 in total

1.  Life on hold: the experience of living with neuromyelitis optica.

Authors:  Kerry Mutch; Abigail Methley; Phil Moore; Anu Jacob
Journal:  Disabil Rehabil       Date:  2013-09-12       Impact factor: 3.033

2.  Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series.

Authors:  Laura Azzopardi; Amanda L Cox; Claire L McCarthy; Joanne L Jones; Alasdair J Coles
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

3.  Cognitive impairment in Chinese neuromyelitis optica.

Authors:  N Zhang; Y J Li; Y Fu; J H Shao; L L Luo; L Yang; F D Shi; Y Liu
Journal:  Mult Scler       Date:  2015-03-31       Impact factor: 6.312

4.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-09-27       Impact factor: 8.322

5.  Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis.

Authors:  David B Clifford; Beau Ances; Craig Costello; Shari Rosen-Schmidt; Magnus Andersson; Deborah Parks; Arie Perry; Raju Yerra; Robert Schmidt; Enrique Alvarez; Kenneth L Tyler
Journal:  Arch Neurol       Date:  2011-05-09

6.  Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.

Authors:  Gurumoorthy Krishnamoorthy; Hans Lassmann; Hartmut Wekerle; Andreas Holz
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

7.  Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis.

Authors:  Brian G Weinshenker; Dean M Wingerchuk; Sandra Vukusic; Linda Linbo; Sean J Pittock; Claudia F Lucchinetti; Vanda A Lennon
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

8.  Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.

Authors:  Shannon R Hinson; Andrew McKeon; James P Fryer; Metha Apiwattanakul; Vanda A Lennon; Sean J Pittock
Journal:  Arch Neurol       Date:  2009-09

Review 9.  Regenerative cellular therapies for neurologic diseases.

Authors:  Michael Levy; Nicholas Boulis; Mahendra Rao; Clive N Svendsen
Journal:  Brain Res       Date:  2015-07-31       Impact factor: 3.252

10.  Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab.

Authors:  Jens Harmel; Marius Ringelstein; Jens Ingwersen; Christian Mathys; Norbert Goebels; Hans-Peter Hartung; Sven Jarius; Orhan Aktas
Journal:  BMC Neurol       Date:  2014-12-17       Impact factor: 2.474
View more
  11 in total

1.  Screening for cognitive impairment among patients with neuromyelitis optica using touchscreen cognitive testing in routine clinical care.

Authors:  Jack Cotter; Fiona Trew; Shuna Colville; Dawn Lyle; Denise Cranley; Francesca Cormack; Jennifer H Barnett; Katy Murray; Suvankar Pal
Journal:  J Neurol       Date:  2019-06-20       Impact factor: 4.849

Review 2.  Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.

Authors:  Jayne L Chamberlain; Saif Huda; Daniel H Whittam; Marcelo Matiello; B Paul Morgan; Anu Jacob
Journal:  J Neurol       Date:  2019-09-03       Impact factor: 4.849

Review 3.  Neuromyelitis optica spectrum disorders.

Authors:  Saif Huda; Dan Whittam; Maneesh Bhojak; Jayne Chamberlain; Carmel Noonan; Anu Jacob
Journal:  Clin Med (Lond)       Date:  2019-03       Impact factor: 2.659

4.  Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD.

Authors:  Lawrence J Cook; John W Rose; Jessica S Alvey; Anna Marie Jolley; Renee Kuhn; Brie Marron; Melissa Pederson; Rene Enriquez; Jeff Yearley; Stephen McKechnie; May H Han; Anna J Tomczak; Michael Levy; Maureen A Mealy; Jessica Coleman; Jeffrey L Bennett; Ruth Johnson; Myka Barnes-Garcia; Anthony L Traboulsee; Robert L Carruthers; Lisa Eunyoung Lee; Julia J Schubert; Katrina McMullen; Ilya Kister; Zoe Rimler; Allyson Reid; Nancy L Sicotte; Sarah M Planchon; Jeffrey A Cohen; Diane Ivancic; Jennifer L Sedlak; Ilana Katz Sand; Pavle Repovic; Lilyana Amezcua; Ana Pruitt; Erika Amundson; Tanuja Chitnis; Devin S Mullin; Eric C Klawiter; Andrew W Russo; Claire S Riley; Kaho B Onomichi; Libby Levine; Katherine E Nelson; Nancy M Nealon; Casey Engel; Mason Kruse-Hoyer; Melanie Marcille; Leticia Tornes; Anne Rumpf; Angela Greer; Megan Kenneally Behne; Renee R Rodriguez; Daniel W Behne; Derek W Blackway; Brian Coords; Terrence F Blaschke; Judy Sheard; Terry J Smith; Jacinta M Behne; Michael R Yeaman
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-06-28

5.  Neuromyelitis optica spectrum disorder: Patient experience and quality of life.

Authors:  Janine Beekman; Aysha Keisler; Omar Pedraza; Masayuki Haramura; Athos Gianella-Borradori; Eliezer Katz; John N Ratchford; Gerard Barron; Lawrence J Cook; Jacinta M Behne; Terrence F Blaschke; Terry J Smith; Michael R Yeaman
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-06-20

6.  Plasma Exchange as a First Line Therapy in Acute Attacks of Neuromyelitis Optica Spectrum Disorders.

Authors:  B L Kumawat; Reenu Choudhary; C M Sharma; Deepak Jain; Ashwini Hiremath
Journal:  Ann Indian Acad Neurol       Date:  2019-10-25       Impact factor: 1.383

Review 7.  Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations.

Authors:  Jinming Han; Meng-Ge Yang; Jie Zhu; Tao Jin
Journal:  Neuropsychiatr Dis Treat       Date:  2017-10-20       Impact factor: 2.570

Review 8.  Case for a new corticosteroid treatment trial in optic neuritis: review of updated evidence.

Authors:  Axel Petzold; Tasanee Braithwaite; Bob W van Oosten; Lisanne Balk; Elena H Martinez-Lapiscina; Russell Wheeler; Nils Wiegerinck; Christiaan Waters; Gordon T Plant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-11-18       Impact factor: 10.154

Review 9.  Cognitive impairment in NMOSD-More questions than answers.

Authors:  Dominika Czarnecka; Magdalena Oset; Iwona Karlińska; Mariusz Stasiołek
Journal:  Brain Behav       Date:  2020-10-06       Impact factor: 2.708

10.  Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis.

Authors:  Isabel Charlotte Hostettler; Duncan Wilson; Catherine Arnold Fiebelkorn; Diane Aum; Sebastián Francisco Ameriso; Federico Eberbach; Markus Beitzke; Timothy Kleinig; Thanh Phan; Sarah Marchina; Romain Schneckenburger; Maria Carmona-Iragui; Andreas Charidimou; Isabelle Mourand; Sara Parreira; Gareth Ambler; Hans Rolf Jäger; Shaloo Singhal; John Ly; Henry Ma; Emmanuel Touzé; Ruth Geraldes; Ana Catarina Fonseca; Teresa Melo; Pierre Labauge; Pierre-Henry Lefèvre; Anand Viswanathan; Steven Mark Greenberg; Juan Fortea; Marion Apoil; Marion Boulanger; Fausto Viader; Sandeep Kumar; Velandai Srikanth; Ashan Khurram; Franz Fazekas; Veronica Bruno; Gregory Joseph Zipfel; Daniel Refai; Alejandro Rabinstein; Jonathan Graff-Radford; David John Werring
Journal:  J Neurol       Date:  2021-07-17       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.